Actively Recruiting
Study of MR-based IGRT for Prostate Cancer
Led by University Hospital Tuebingen · Updated on 2019-09-25
78
Participants Needed
1
Research Sites
652 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.
CONDITIONS
Official Title
Study of MR-based IGRT for Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically proven prostate cancer
- Indication for curative treatment
- ECOG performance status of 0 to 2
- Provided informed consent
You will not qualify if you...
- Contraindications for curative treatment
- Age under 18 years
- Previous pelvic radiotherapy or prostate treatments like TURP or HIFU
- Serious medical conditions preventing participation in IGRT
- Contraindications for MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Müller Arndt-Christian
Tübingen, Germany, 72076
Actively Recruiting
Research Team
A
Arndt-Christian Müller, Dr.
CONTACT
D
Daniel Zips, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here